Roche announced it's building autonomous AI-powered labs; how a clinical hold on an epilepsy trial could impact Biohaven ...

Companies including GSK, Merck, Roche and Sanofi are pushing new approaches in cancer and inflammatory diseases.

Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could ...

The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety concerns: What ...

There’s no shortage of epilepsy drugs — the FDA has approved more than 30 antiseizure medications for the condition to date. Yet roughly a third of epilepsy patients continue to have uncontrolled ...

The Danish biotech sharpened its global vaccine ambitions by tapping Tarja Stenvall, a Big Pharma vet, to take the helm.

Nimbus Therapeutics’ head of R&D dishes on what’s next in AI-enabled drug discovery, years after Takeda completed its ...

Basecamp Research just netted $140 million in a series C fundraising round that valued the company at $800 million, according ...